Genetically Engineered Mouse Models of Neurodegenerative Disorders

作者: Eliezer Masliah , Leslie Crews

DOI: 10.1007/0-387-25919-8_19

关键词:

摘要: Considerable advances have been made in the past years developing novel experimental models of neurodegenerative disorders, including Alzheimer’s disease (AD), Parkinson’s (PD), Fronto-Temporal Dementias (FTD), Amyotrophic Lateral Sclerosis (ALS), and trinucleotide repeat disorders (TNRDs). The main postulate several genetically modified murine is that a single molecular alteration might trigger cascade events eventually will result full spectrum clinicopathological alterations observed human disease. Therefore, overexpression mutant proteins transgenic (tg) mice mimic some aspects associated with gain toxic function, while targeted deletion selected genes loss trophic or protective function. To date, identified to be familial forms AD, PD, FTD, ALS, TNRDs. Single combined tg knockout targeting most these developed recapitulate one each disorder. In models, abnormal accumulation misfolding (toxic conversion) endogenous being extensively explored as key pathogenic event leading neurodegeneration. Thus, focus this chapter provide perspective efforts engineered common disorders. Further development investigation animal diseases holds promise better understanding their pathogenesis discovering testing new treatments.

参考文章(285)
E B Langston, I Irwin, J W Langston, MPTP-induced parkinsonism in human and non-human primates--clinical and experimental aspects. Acta Neurologica Scandinavica. ,vol. 100, pp. 49- 54 ,(1984)
E. Masliah, E. Rockenstein, Genetically altered transgenic models of Alzheimer’s disease Advances in Dementia Research. ,vol. 59, pp. 175- 183 ,(2000) , 10.1007/978-3-7091-6781-6_20
E Masliah, M Mallory, M Alford, R Terry, R DeTeresa, L Hansen, An antibody against phosphorylated neurofilaments identifies a subset of damaged association axons in Alzheimer's disease American Journal of Pathology. ,vol. 142, pp. 871- 882 ,(1993)
E Masliah, M Sundsmo, A Takeda, M Mallory, W Honer, L Hansen, Abnormal accumulation of NACP/alpha-synuclein in neurodegenerative disorders American Journal of Pathology. ,vol. 152, pp. 367- 372 ,(1998)
D. W. Dickson, M. B. Feany, S.-H. Yen, L. A. Mattiace, P. Davies, Cytoskeletal pathology in non-Alzheimer degenerative dementia: new lesions in Diffuse Lewy body disease, Pick’s disease, and Corticobasal Degeneration Journal of Neural Transmission Supplement. ,vol. 47, pp. 31- 46 ,(1996) , 10.1007/978-3-7091-6892-9_2
Heimut Jacobsen, Guy A. Higgins, Transgenic mouse models of Alzheimer's disease: phenotype and application. Behavioural Pharmacology. ,vol. 14, pp. 419- 438 ,(2003) , 10.1097/01.FBP.0000088420.18414.FF
Poul H. JENSEN, Peter HØJRUP, Henrik HAGER, Morten S. NIELSEN, Linda JACOBSEN, Ole F. OLESEN, Jørgen GLIEMANN, Ross JAKES, Binding of Abeta to alpha- and beta-synucleins: identification of segments in alpha-synuclein/NAC precursor that bind Abeta and NAC. Biochemical Journal. ,vol. 323, pp. 539- 546 ,(1997) , 10.1042/BJ3230539
D. Games, E. Masliah, M. Lee, K. Johnson-Wood, D. Schenk, Neurodegenerative Alzheimer-like Pathology in PDAPP 717V → F Transgenic Mice Connections, Cognition and Alzheimer’s Disease. ,vol. 117, pp. 105- 119 ,(1997) , 10.1007/978-3-642-60680-9_8